Cargando…
Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider
Glucocorticoids (prednisone) are essential in the treatment of RA and other autoimmune diseases. They are widely used, but treatment guidelines advise against. This viewpoint article explains why and suggests a way forward.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629782/ https://www.ncbi.nlm.nih.gov/pubmed/37338537 http://dx.doi.org/10.1093/rheumatology/kead309 |
| _version_ | 1785132027577630720 |
|---|---|
| author | Boers, Maarten |
| author_facet | Boers, Maarten |
| author_sort | Boers, Maarten |
| collection | PubMed |
| description | Glucocorticoids (prednisone) are essential in the treatment of RA and other autoimmune diseases. They are widely used, but treatment guidelines advise against. This viewpoint article explains why and suggests a way forward. |
| format | Online Article Text |
| id | pubmed-10629782 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106297822023-11-08 Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider Boers, Maarten Rheumatology (Oxford) Review Glucocorticoids (prednisone) are essential in the treatment of RA and other autoimmune diseases. They are widely used, but treatment guidelines advise against. This viewpoint article explains why and suggests a way forward. Oxford University Press 2023-06-20 /pmc/articles/PMC10629782/ /pubmed/37338537 http://dx.doi.org/10.1093/rheumatology/kead309 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Review Boers, Maarten Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider |
| title | Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider |
| title_full | Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider |
| title_fullStr | Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider |
| title_full_unstemmed | Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider |
| title_short | Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider |
| title_sort | viewpoint: glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629782/ https://www.ncbi.nlm.nih.gov/pubmed/37338537 http://dx.doi.org/10.1093/rheumatology/kead309 |
| work_keys_str_mv | AT boersmaarten viewpointglucocorticoidsinthetreatmentofrheumatoidarthritispointstoreconsider |